At the heart of the ICPO Foundation’s mission lies the development of a strong global network of experts dedicated to advancing theranostics. This ICPO Community unites leaders from clinical practice, research, industry, and non-profit associations as well as nuclear medicine societies. To connect with experts across continents and stay at the forefront of Theranostics innovation the ICPO Foundation hosts two flagship events and participates in conferences on nuclear medicine and Theranostics worldwide.
At the ICPO Theranostics Virtual Summit, leading international Theranostics experts from the ICPO community will present the latest innovations, clinical insights, and patient-focused advances shaping the future of Theranostics. Attendees from around the globe have the opportunity to engage directly with the chairs and speakers in an interactive virtual setting. The online event takes place every two years.
The ICPO Forum is a biennial in-person event organized at the TUM Campus in Munich, Germany, featuring a unique scientific program that brings together international specialists to debate the biggest challenges and recent advancements in Theranostics worldwide. Take advantage of this opportunity to connect with the global ICPO community and build valuable networks, aiming together for improved patient outcomes.
“I attended every lecture from Boston, USA, and enjoyed every one of them (even today at 3 am in the morning…) including the panels. It was wonderful to see that biological knowledge needs indeed to be fully understood and included in our decision making in order to make the best decision both for the diagnosis and the treatment of cancer on a patient-centric base for clinical trials and in routine care.“
Prof. Annick D. Van den Abbeele, Professor of Radiology, Harvard Medical School, Boston, USA
“The ICPO Forum for Theranostics 2025 has demonstrated the fast evolution of our field and current challenges this brings. ICPO has a role to play especially towards low and medium countries which represent huge patient numbers and unmet clinical needs. The interdisciplinary energy created during the ICPO Forum is exactly what we need to advance Theranostics. The discussions clearly illustrated that Theranostics is becoming a new and valuable pillar of precision oncology.”
Prof. Ken Herrmann, Chair of the Department of Nuclear Medicine, University Hospital Essen, Germany
